Alyssa Weakley

Alyssa Weakley is a value and access leader at Amgen with nearly a decade of experience in the healthcare sector. Currently, Alyssa serves as the Senior Manager of Coverage and Pricing Strategy for the Inflammation Biosimilars Portfolio, focusing on strategic coverage negotiations for biosimilars. Previously, Alyssa held various roles at Amgen, where they led launch strategies, developed engagement tools, and managed employer-focused marketing initiatives. Alyssa also gained valuable experience through internships in government affairs and advocacy, further solidifying their expertise in policy and strategy. They are an MBA candidate at UCLA Anderson School of Management and hold a BA in Political Science with a business minor from The George Washington University.